@article{article, title = {{Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},
url = {{http://eprints.whiterose.ac.uk/141166/ }},
year = {{2018}},
month = {{12}},
author = {{Ren S and Squires H and Hock E and Kaltenthaler E and Rawdin A and Alifrangis C}},
doi = {{10.1007/s40273-018-0750-2}},
journal = {{PharmacoEconomics}},
note = {{Accessed on 2025/01/07}}}